HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
Will Fischer, Elena E Giorgi, Srirupa Chakraborty, Kien Nguyen, Tanmoy Bhattacharya, James Theiler, Pablo A Goloboff, Hyejin Yoon, Werner Abfalterer, Brian T Foley, Houriiyah Tegally, James Emmanuel San, Tulio de Oliveira, Network for Genomic Surveillance in South Africa (NGS-SA), Sandrasegaram Gnanakaran, Bette Korber, Eduan Wilkinson, Nokukhanya Msomi, Arash Iranzadeh, Vagner Fonseca, Deelan Doolabh, Koleka Mlisana, Anne von Gottberg, Sibongile Walaza, Mushal Allam, Arshad Ismail, Thabo Mohale, Allison J Glass, Susan Engelbrecht, Gert Van Zyl, Wolfgang Preiser, Francesco Petruccione, Alex Sigal, Diana Hardie, Gert Marais, Marvin Hsiao, Stephen Korsman, Mary-Ann Davies, Lynn Tyers, Innocent Mudau, Denis York, Caroline Maslo, Dominique Goedhals, Shareef Abrahams, Oluwakemi Laguda-Akingba, Arghavan Alisoltani-Dehkordi, Adam Godzik, Constantinos Kurt Wibmer, Bryan Trevor Sewell, José Lourenço, Sergei L Kosakovsky Pond, Steven Weaver, Marta Giovanetti, Luiz Carlos Junior Alcantara, Darren Martin, Jinal N Bhiman, Carolyn Williamson, Will Fischer, Elena E Giorgi, Srirupa Chakraborty, Kien Nguyen, Tanmoy Bhattacharya, James Theiler, Pablo A Goloboff, Hyejin Yoon, Werner Abfalterer, Brian T Foley, Houriiyah Tegally, James Emmanuel San, Tulio de Oliveira, Network for Genomic Surveillance in South Africa (NGS-SA), Sandrasegaram Gnanakaran, Bette Korber, Eduan Wilkinson, Nokukhanya Msomi, Arash Iranzadeh, Vagner Fonseca, Deelan Doolabh, Koleka Mlisana, Anne von Gottberg, Sibongile Walaza, Mushal Allam, Arshad Ismail, Thabo Mohale, Allison J Glass, Susan Engelbrecht, Gert Van Zyl, Wolfgang Preiser, Francesco Petruccione, Alex Sigal, Diana Hardie, Gert Marais, Marvin Hsiao, Stephen Korsman, Mary-Ann Davies, Lynn Tyers, Innocent Mudau, Denis York, Caroline Maslo, Dominique Goedhals, Shareef Abrahams, Oluwakemi Laguda-Akingba, Arghavan Alisoltani-Dehkordi, Adam Godzik, Constantinos Kurt Wibmer, Bryan Trevor Sewell, José Lourenço, Sergei L Kosakovsky Pond, Steven Weaver, Marta Giovanetti, Luiz Carlos Junior Alcantara, Darren Martin, Jinal N Bhiman, Carolyn Williamson
Abstract
Humanity is currently facing the challenge of two devastating pandemics caused by two very different RNA viruses: HIV-1, which has been with us for decades, and SARS-CoV-2, which has swept the world in the course of a single year. The same evolutionary strategies that drive HIV-1 evolution are at play in SARS-CoV-2. Single nucleotide mutations, multi-base insertions and deletions, recombination, and variation in surface glycans all generate the variability that, guided by natural selection, enables both HIV-1's extraordinary diversity and SARS-CoV-2's slower pace of mutation accumulation. Even though SARS-CoV-2 diversity is more limited, recently emergent SARS-CoV-2 variants carry Spike mutations that have important phenotypic consequences in terms of both antibody resistance and enhanced infectivity. We review and compare how these mutational patterns manifest in these two distinct viruses to provide the variability that fuels their evolution by natural selection.
Keywords: HIV-1; SARS-CoV-2; evolution; glycosylation; immune escape; insertions and deletions; recombination.
Conflict of interest statement
Declaration of interests B.K., W.F., J.T., T.B., and S.G. have provisional patents and patents relating to vaccine design to address viral diversity as applied to HIV-1 and/or SARS-CoV-2.
Published by Elsevier Inc.
Figures
References
- Arendrup M., Nielsen C., Hansen J.E., Pedersen C., Mathiesen L., Nielsen J.O. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J. Acquir. Immune Defic. Syndr. (1988) 1992;5:303–307.
- Avanzato V.A., Matson M.J., Seifert S.N., Pryce R., Williamson B.N., Anzick S.L., Barbian K., Judson S.D., Fischer E.R., Martens C., et al. Case study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. 2020;183:1901–1912.e9.
- Baang J.H., Smith C., Mirabelli C., Valesano A.L., Manthei D.M., Bachman M.A., Wobus C.E., Adams M., Washer L., Martin E.T., Lauring A.S. Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient. J. Infect. Dis. 2021;223:23–27.
- Bar K.J., Tsao C.Y., Iyer S.S., Decker J.M., Yang Y., Bonsignori M., Chen X., Hwang K.K., Montefiori D.C., Liao H.X., et al. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog. 2012;8:e1002721.
- Baric R.S., Fu K., Schaad M.C., Stohlman S.A. Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups. Virology. 1990;177:646–656.
- Bartolini B., Rueca M., Gruber C.E.M., Messina F., Giombini E., Ippolito G., Capobianchi M.R., Di Caro A. The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region, Italy. medRxiv. 2020 doi: 10.1101/2020.11.28.20237016.
- Bbosa N., Kaleebu P., Ssemwanga D. HIV subtype diversity worldwide. Curr. Opin. HIV AIDS. 2019;14:153–160.
- Behrens A.J., Vasiljevic S., Pritchard L.K., Harvey D.J., Andev R.S., Krumm S.A., Struwe W.B., Cupo A., Kumar A., Zitzmann N., et al. Composition and antigenic effects of individual glycan sites of a trimeric HIV-1 Envelope glycoprotein. Cell Rep. 2016;14:2695–2706.
- Berndsen Z.T., Chakraborty S., Wang X., Cottrell C.A., Torres J.L., Diedrich J.K., López C.A., Yates J.R., 3rd, van Gils M.J., Paulson J.C., et al. Visualization of the HIV-1 Env glycan shield across scales. Proc. Natl. Acad. Sci. USA. 2020;117:28014–28025.
- Bhiman J.N., Anthony C., Doria-Rose N.A., Karimanzira O., Schramm C.A., Khoza T., Kitchin D., Botha G., Gorman J., Garrett N.J., et al. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat. Med. 2015;21:1332–1336.
- Billings E., Kijak G.H., Sanders-Buell E., Ndembi N., OʼSullivan A.M., Adebajo S., Kokogho A., Milazzo M., Lombardi K., Baral S., et al. MHRP Viral Sequencing Core and the TRUST/RV368 Study Group New subtype B containing HIV-1 circulating recombinant of sub-Saharan Africa origin in Nigerian men who have sex with men. J. Acquir. Immune Defic. Syndr. 2019;81:578–584.
- Bonsignori M., Kreider E.F., Fera D., Meyerhoff R.R., Bradley T., Wiehe K., Alam S.M., Aussedat B., Walkowicz W.E., Hwang K.K., et al. Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. Sci. Transl. Med. 2017;9:eaai7514.
- Bonsignori M., Zhou T., Sheng Z., Chen L., Gao F., Joyce M.G., Ozorowski G., Chuang G.Y., Schramm C.A., Wiehe K., et al. NISC Comparative Sequencing Program Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody. Cell. 2016;165:449–463.
- Boutwell C.L., Rolland M.M., Herbeck J.T., Mullins J.I., Allen T.M. Viral evolution and escape during acute HIV-1 infection. J. Infect. Dis. 2010;202(Suppl 2):S309–S314.
- Bouvet M., Imbert I., Subissi L., Gluais L., Canard B., Decroly E. RNA 3¢-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex. Proc. Natl. Acad. Sci. USA. 2012;109:9372–9377.
- Bricault C.A., Yusim K., Seaman M.S., Yoon H., Theiler J., Giorgi E.E., Wagh K., Theiler M., Hraber P., Macke J.P., et al. HIV-1 neutralizing antibody signatures and application to epitope-targeted vaccine design. Cell Host Microbe. 2019;26:296.
- Bugembe D.L., Phan M.V.T., Ssewanyana I., Semanda P., Nansumba H., Dhaala B., Nabadda S., O’Toole Á.N., Rambaut A., Kaleebu P., Cotten M. A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic. medRxiv. 2021 2021.02.08.21251393.
- Burnie J., Guzzo C. The Incorporation of Host Proteins into the External HIV-1 Envelope. Viruses. 2019;11:85.
- Centers for Disease Control (CDC) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb. Mortal. Wkly. Rep. 1981;30:305–308.
- Cerutti G., Guo Y., Zhou T., Gorman J., Lee M., Rapp M., Reddem E.R., Yu J., Bahna F., Bimela J., Huang Y., Katsamba P.S., Liu L., Nair M.S., Rawi R., Olia A.S., Wang P., Chuang G.Y., Ho D.D., Sheng Z., Kwong P.D., Shapiro L. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. bioRxiv. 2021 2021.01.10.426120.
- Chakraborty S., Berndsen Z.T., Hengartner N.W., Korber B.T., Ward A.B., Gnanakaran S. Quantification of the resilience and vulnerability of HIV-1 native glycan shield at atomistic detail. iScience. 2020;23:101836.
- Chi X., Yan R., Zhang J., Zhang G., Zhang Y., Hao M., Zhang Z., Fan P., Dong Y., Yang Y., et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020;369:650–655.
- Choi B., Choudhary M.C., Regan J., Sparks J.A., Padera R.F., Qiu X., Solomon I.H., Kuo H.H., Boucau J., Bowman K., et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 2020;383:2291–2293.
- Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181–192.
- Dashti A., DeVico A.L., Lewis G.K., Sajadi M.M. Broadly neutralizing antibodies against HIV: Back to blood. Trends Mol. Med. 2019;25:228–240.
- Davies N.G., Barnard R.C., Jarvis C.I., Kucharski A.J., Munday J., Pearson C.A.B., Russell T.W., Tully D.C., Abbott S., Gimma A., Waites W., Wong K.L.M., van Zandvoort K., Eggo R.M., Funk S., Jit M., Atkins K.E., Edmunds W.J. Estimated transmissibility and severity of novel SARS-CoV-2 variant of concern 202012/01 in England. medRxiv. 2020 2020.12.24.20248822.
- De Maio N., Walker C., Borges R., Weilguny L., Slodkowicz G., Goldman N. Issues with SARS-CoV-2 sequencing data. 2020.
- Deng X., Garcia-Knight M.A., Khalid M.M., Servellita V., Wang C., Morris M.K., Sotomayor-Gonźalez A., Glasner D.R., Reyes K.R., Gliwa A.S., et al. Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation. medRxiv. 2021 2021.03.07.21252647.
- Denison M.R., Graham R.L., Donaldson E.F., Eckerle L.D., Baric R.S. Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biol. 2011;8:270–279.
- Di Giorgio S., Martignano F., Torcia M.G., Mattiuz G., Conticello S.G. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci. Adv. 2020;6:eabb5813.
- Donnelly C.A., Malik M.R., Elkholy A., Cauchemez S., Van Kerkhove M.D. Worldwide Reduction in MERS Cases and Deaths since 2016. Emerg. Infect. Dis. 2019;25:1758–1760.
- van Dorp L., Tan C.C., Lam S.D., Richard D., Owen C., Berchtold D., Orengo C., Balloux F. Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation. bioRxiv. 2020 doi: 10.1101/2020.11.16.384743.
- Dumiak M. The race is on. IAVI Rep. 2020;24
- European Centre for Disease Prevention and Control . European Centre for Disease Prevention and Control; 2020. Detection of new SARS-CoV-2 variants related to mink. Technical Report.
- Fischer W., Ganusov V.V., Giorgi E.E., Hraber P.T., Keele B.F., Leitner T., Han C.S., Gleasner C.D., Green L., Lo C.C., et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One. 2010;5:e12303.
- Gao F., Bonsignori M., Liao H.X., Kumar A., Xia S.M., Lu X., Cai F., Hwang K.K., Song H., Zhou T., et al. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell. 2014;158:481–491.
- Ghebreyesus T.A. World Health Organization (WHO); 2020. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020. (press release). 11 March 2020.
- Giorgi E.E., Bhattacharya T., Fischer W., Yoon H., Abfalterer W., Korber B. Recombination and low-diversity confound homoplasy-based methods to detect the effect of SARS-CoV-2 mutations on viral transmissibility. bioRxiv. 2021 2021.01.29.428535.
- Giorgi J.V., Lyles R.H., Matud J.L., Yamashita T.E., Mellors J.W., Hultin L.E., Jamieson B.D., Margolick J.B., Rinaldo C.R., Jr., Phair J.P., Detels R., Multicenter AIDS Cohort Study Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 2002;29:346–355.
- Goh J.B., Ng S.K. Impact of host cell line choice on glycan profile. Crit. Rev. Biotechnol. 2018;38:851–867.
- Goloboff P.A., Catalano S.A. TNT version 1.5, including a full implementation of phylogenetic morphometrics. Cladistics. 2016;32:221–238.
- Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536–544.
- Graham R.L., Baric R.S. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J. Virol. 2010;84:3134–3146.
- Grant H.E., Hodcroft E.B., Ssemwanga D., Kitayimbwa J.M., Yebra G., Esquivel Gomez L.R., Frampton D., Gall A., Kellam P., de Oliveira T., Bbosa N., Nsubuga R.N., Kibengo F., Kwan T.H., Lycett S., Kao R., Robertson D.L., Ratmann O., Fraser C., Pillay D., Kaleebu P., Leigh Brown A.J. Pervasive and non-random recombination in near full-length HIV genomes from Uganda. Virus Evol. 2020;6:veaa004.
- Hahn B.H., Shaw G.M., De Cock K.M., Sharp P.M. AIDS as a zoonosis: scientific and public health implications. Science. 2000;287:607–614.
- Hasenkrug K.J., Feldmann F., Myers L., Santiago M.L., Guo K., Barrett B.S., Mickens K.L., Carmody A., Okumura A., Rao D., et al. Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques. bioRxiv. 2021 2021.2004.2002.438262.
- Haynes B.F., Burton D.R., Mascola J.R. Multiple roles for HIV broadly neutralizing antibodies. Sci. Transl. Med. 2019;11:eaaz2686.
- He X., Lau E.H.Y., Wu P., Deng X., Wang J., Hao X., Lau Y.C., Wong J.Y., Guan Y., Tan X., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 2020;26:672–675.
- Hemelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Fleminger I., Kirtley S., Williams B., Gouws-Williams E., Ghys P.D., WHO–UNAIDS Network for HIV Isolation Characterisation Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect. Dis. 2019;19:143–155.
- Hensley M.K., Bain W.G., Jacobs J., Nambulli S., Parikh U., Cillo A., Staines B., Heaps A., Sobolewski M.D., Rennick L.J., et al. Intractable COVID-19 and prolonged SARS-CoV-2 replication in a chimeric antigen receptor-modified T-Cell therapy recipient: A case study. Clin. Infect. Dis. 2021:ciab072.
- Hodcroft E.B., Zuber M., Nadeau S., Crawford K.H.D., Bloom J.D., Veesler D., Vaughan T.G., Comas I., Candelas F.G., Stadler T., Neher R.A. Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020. medRxiv. 2020 2020.10.25.20219063.
- Hon C.C., Lam T.Y., Shi Z.L., Drummond A.J., Yip C.W., Zeng F., Lam P.Y., Leung F.C.C. Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus. J. Virol. 2008;82:1819–1826.
- Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H., Leist S.R., Schäfer A., Nakajima N., Takahashi K., et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science. 2020;370:1464–1468.
- Hraber P., Korber B.T., Lapedes A.S., Bailer R.T., Seaman M.S., Gao H., Greene K.M., McCutchan F., Williamson C., Kim J.H., et al. Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies. J. Virol. 2014;88:12623–12643.
- Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 1996;14:33–38. 27–8.
- Hymes K.B., Cheung T., Greene J.B., Prose N.S., Marcus A., Ballard H., William D.C., Laubenstein L.J. Kaposi’s sarcoma in homosexual men-a report of eight cases. Lancet. 1981;2:598–600.
- Johnson B.A., Xie X., Bailey A.L., Kalveram B., Lokugamage K.G., Muruato A., Zou J., Zhang X., Juelich T., Smith J.K., et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021;591:293–299.
- Kemp S., Meng B., Ferriera I., Datir R., Harvey W., Collier D., Lytras S., Papa G., Carabelli A., Kenyon J., et al. Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70. bioRxiv. 2021 2020.12.14.422555.
- Kemp S.A., Collier D.A., Datir R.P., Ferreira I.A.T.M., Gayed S., Jahun A., Hosmillo M., Rees-Spear C., Mlcochova P., Lumb I.U., et al. CITIID-NIHR BioResource COVID-19 Collaboration. COVID-19 Genomics UK (COG-UK) Consortium SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592:277–282.
- Kiwelu I.E., Novitsky V., Margolin L., Baca J., Manongi R., Sam N., Shao J., McLane M.F., Kapiga S.H., Essex M. Frequent intra-subtype recombination among HIV-1 circulating in Tanzania. PLoS One. 2013;8:e71131.
- Korber B., Fischer W. T cell-based strategies for HIV-1 vaccines. Hum. Vaccin. Immunother. 2020;16:713–722.
- Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W., Foley B., Giorgi E.E., Bhattacharya T., Parker M.D., et al. Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. bioRxiv. 2020 2020.04.29.069054.
- Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W., Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., et al. Sheffield COVID-19 Genomics Group Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812–827.e19.
- Korber B., Hraber P., Wagh K., Hahn B.H. Polyvalent vaccine approaches to combat HIV-1 diversity. Immunol. Rev. 2017;275:230–244.
- Korber B., Muldoon M., Theiler J., Gao F., Gupta R., Lapedes A., Hahn B.H., Wolinsky S., Bhattacharya T. Timing the ancestor of the HIV-1 pandemic strains. Science. 2000;288:1789–1796.
- Kozlov A.M., Darriba D., Flouri T., Morel B., Stamatakis A. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics. 2019;35:4453–4455.
- Krakoff E., Gagne R.B., VandeWoude S., Carver S. Variation in intra-individual lentiviral evolution rates: a systematic review of human, nonhuman primate, and felid species. J. Virol. 2019;93:e00538-19.
- Kwon Y.D., Pancera M., Acharya P., Georgiev I.S., Crooks E.T., Gorman J., Joyce M.G., Guttman M., Ma X., Narpala S., et al. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat. Struct. Mol. Biol. 2015;22:522–531.
- Lam T.T.Y., Jia N., Zhang Y.W., Shum M.H.H., Jiang J.F., Zhu H.C., Tong Y.G., Shi Y.X., Ni X.B., Liao Y.S., et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583:282–285.
- Lassaunière R., Fonager J., Rasmussen M., Frische A., Strandh C.P., Rasmussen T.B., Bøtner A., Fomsgaard A. Statens Serum Institut.; 2020. Working paper on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data. Technical Report.
- Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H., Nie L., et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 2020;182:1284–1294.e9.
- Li X., Giorgi E.E., Marichannegowda M.H., Foley B., Xiao C., Kong X.P., Chen Y., Gnanakaran S., Korber B., Gao F. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Science Advances. 2020;6:eabb9153.
- Li Y., Ndjango J.B., Learn G.H., Ramirez M.A., Keele B.F., Bibollet-Ruche F., Liu W., Easlick J.L., Decker J.M., Rudicell R.S., et al. Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir. J. Virol. 2012;86:10776–10791.
- Liu M.K.P., Hawkins N., Ritchie A.J., Ganusov V.V., Whale V., Brackenridge S., Li H., Pavlicek J.W., Cai F., Rose-Abrahams M., et al. CHAVI Core B Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J. Clin. Invest. 2013;123:380–393.
- Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Euro Surveill. 2021;26:2002106.
- Malim M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009;364:675–687.
- Mansbach R.A., Chakraborty S., Nguyen K., Montefiori D.C., Korber B., Gnanakaran S. The SARS-CoV-2 Spike variant D614G favors an open conformational state. Sci. Adv. 2021;7:eabf3671.
- Mansky L.M., Temin H.M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 1995;69:5087–5094.
- McCallum M., De Marco A., Lempp F.A., Tortorici M.A., Pinto D., Walls A.C., Beltramello M., Chen A., Liu Z., Zatta F., et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021;184:2332–2347.e16.
- McCallum M., Bassi J., Marco A., Chen A., Walls A.C., Iulio J.D., Tortorici M.A., Navarro M.J., Silacci-Fregni C., Saliba C., et al. SARS-CoV-2 immune evasion by variant B.1.427/B.1.429. bioRxiv. 2021 doi: 10.1101/2021.03.31.437925. 2021.03.31.437925.
- McCarthy K.R., Rennick L.J., Nambulli S., Robinson-McCarthy L.R., Bain W.G., Haidar G., Duprex W.P. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021;371:1139–1142.
- McMahan K., Yu J., Mercado N.B., Loos C., Tostanoski L.H., Chandrashekar A., Liu J., Peter L., Atyeo C., Zhu A., et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021;590:630–634.
- Meyerowitz E.A., Richterman A., Gandhi R.T., Sax P.E. Transmission of SARS-CoV-2: A review of viral, host, and environmental factors. Ann. Intern. Med. 2021;174:69–79.
- Moore J.P., Wilson I.A. STAT News; 2021. Decades of basic research paved the way for today’s ‘warp speed’ Covid-19 vaccines.
- Nikolaitchik O., Keele B., Gorelick R., Alvord W.G., Mazurov D., Pathak V.K., Hu W.S. High recombination potential of subtype A HIV-1. Virology. 2015;484:334–340.
- Pal M., Berhanu G., Desalegn C., Kandi V. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020;12:e7423.
- Phillips R.E., Rowland-Jones S., Nixon D.F., Gotch F.M., Edwards J.P., Ogunlesi A.O., Elvin J.G., Rothbard J.A., Bangham C.R., Rizza C.R., et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991;354:453–459.
- Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G., Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592:116–121.
- Rademeyer C., Korber B., Seaman M.S., Giorgi E.E., Thebus R., Robles A., Sheward D.J., Wagh K., Garrity J., Carey B.R., et al. Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: Implications for active and passive immunization. PLoS Pathog. 2016;12:e1005742.
- Rambaut A., Loman N.J., Pybus O.G., Barclay W., Barrett J., Carabelli A.M., Connor T., Peacock T., Robertson D.L.E.,V. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. 2020.
- Rambaut A., Holmes E.C., O’Toole Á., Hill V., McCrone J.T., Ruis C., du Plessis L., Pybus O.G. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 2020;5:1403–1407.
- Rathnasinghe R., Jangra S., Cupic A., Martínez-Romero C., Mulder L.C.F., Kehrer T., Yildiz S., Choi A., Mena I., De Vrieze J., et al. The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera. medRxiv. 2021 doi: 10.1101/2021.01.19.21249592.
- Redd A.D., Nardin A., Kared H., Bloch E.M., Pekosz A., Laeyendecker O., Abel B., Fehlings M., Quinn T.C., Tobian A.A.R. CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants. medRxiv. 2021 2021.02.11.21251585.
- Richman D.D. COVID-19 vaccines: implementation, limitations and opportunities. Glob Health Med. 2021;3:1–5.
- Roark R.S., Li H., Williams W.B., Chug H., Mason R.D., Gorman J., Wang S., Lee F.H., Rando J., Bonsignori M., et al. Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth. Science. 2021;371:eabd2638.
- Robertson D.L., Anderson J.P., Bradac J.A., Carr J.K., Foley B., Funkhouser R.K., Gao F., Hahn B.H., Kalish M.L., Kuiken C., et al. HIV-1 nomenclature proposal. Science. 2000;288:55–56.
- Robson F., Khan K.S., Le T.K., Paris C., Demirbag S., Barfuss P., Rocchi P., Ng W.L. Coronavirus RNA proofreading: Molecular basis and therapeutic targeting. Mol. Cell. 2020;79:710–727.
- Romano M., Ruggiero A., Squeglia F., Maga G., Berisio R. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells. 2020;9:1267.
- Sabir J.S.M., Lam T.T.Y., Ahmed M.M.M., Li L., Shen Y., Abo-Aba S.E.M., Qureshi M.I., Abu-Zeid M., Zhang Y., Khiyami M.A., et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science. 2016;351:81–84.
- Shajahan A., Supekar N.T., Gleinich A.S., Azadi P. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Glycobiology. 2020;30:981–988.
- Sharp P.M., Hahn B.H. Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Med. 2011;1:a006841.
- Shen X., Tang H., McDanal C., Wagh K., Fischer W., Theiler J., Yoon H., Li D., Haynes B.F., Sanders K.O., et al. SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines. Cell Host Microbe. 2021;29:529–539.e3.
- Shriner D., Rodrigo A.G., Nickle D.C., Mullins J.I. Pervasive genomic recombination of HIV-1 in vivo. Genetics. 2004;167:1573–1583.
- Silver Z.A., Antonopoulos A., Haslam S.M., Dell A., Dickinson G.M., Seaman M.S., Desrosiers R.C. Discovery of O-linked carbohydrate on HIV-1 Envelope and its role in shielding against one category of broadly neutralizing antibodies. Cell Rep. 2020;30:1862–1869.e4.
- Song H., Giorgi E.E., Ganusov V.V., Cai F., Athreya G., Yoon H., Carja O., Hora B., Hraber P., Romero-Severson E., et al. Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection. Nat. Commun. 2018;9:1928.
- Stephenson K.E., Wagh K., Korber B., Barouch D.H. Vaccines and broadly neutralizing antibodies for HIV-1 prevention. Annu. Rev. Immunol. 2020;38:673–703.
- Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490–502.
- Tarke A., Sidney J., Kidd C.K., Dan J.M., Ramirez S.I., Yu E.D., Mateus J., da Silva Antunes R., Moore E., Rubiro P., et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep. Med. 2021;2:100204.
- Taylor W.R. Residual colours: a proposal for aminochromography. Protein Eng. 1997;10:743–746.
- Tian J., López C.A., Derdeyn C.A., Jones M.S., Pinter A., Korber B., Gnanakaran S. Effect of glycosylation on an immunodominant region in the V1V2 variable domain of the HIV-1 Envelope gp120 protein. PLoS Comput. Biol. 2016;12:e1005094.
- Toovey O.T.R., Harvey K.N., Bird P.W., Tang J.W.W. Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK. J. Infect. 2021;82:e23–e24.
- Tumban E. Lead SARS-CoV-2 candidate vaccines: Expectations from phase III trials and recommendations post-vaccine approval. Viruses. 2020;13:54.
- UK Collaborative Group on HIV Drug Resistance The increasing genetic diversity of HIV-1 in the UK, 2002-2010. AIDS. 2014;28:773–780.
- Varabyou A., Pockrandt C., Salzberg S.L., Pertea M. Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie. bioRxiv. 2020 2020.09.21.300913v2.
- Volz E., Mishra S., Chand M., Barrett J.C., Johnson R., Geidelberg L., Hinsley W.R., Laydon D.J., Dabrera G., O’Toole A., et al. Transmission of SARS-CoV-2 lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv. 2021 2020.12.30.20249034.
- Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–292.e6.
- Walls A.C., Tortorici M.A., Frenz B., Snijder J., Li W., Rey F.A., DiMaio F., Bosch B.J., Veesler D. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 2016;23:899–905.
- Wang H., Cohen A.A., Galimidi R.P., Gristick H.B., Jensen G.J., Bjorkman P.J. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop. Proc. Natl. Acad. Sci. USA. 2016;113:E7151–E7158.
- Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020;369:330–333.
- Watanabe Y., Berndsen Z.T., Raghwani J., Seabright G.E., Allen J.D., Pybus O.G., McLellan J.S., Wilson I.A., Bowden T.A., Ward A.B., Crispin M. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat. Commun. 2020;11:2688.
- Watanabe Y., Bowden T.A., Wilson I.A., Crispin M. Exploitation of glycosylation in enveloped virus pathobiology. Biochim. Biophys. Acta, Gen. Subj. 2019;1863:1480–1497.
- Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., et al. Antibody neutralization and escape by HIV-1. Nature. 2003;422:307–312.
- Wei Y., Silke J.R., Aris P., Xia X. Coronavirus genomes carry the signatures of their habitats. PLoS One. 2020;15:e0244025.
- Weissman D., Alameh M.G., de Silva T., Collini P., Hornsby H., Brown R., LaBranche C.C., Edwards R.J., Sutherland L., Santra S., et al. D614G Spike mutation increases SARS-CoV-2 susceptibility to neutralization. Cell Host Microbe. 2021;29:23–31.e4.
- West A.P., Barnes C.O., Yang Z., Bjorkman P.J. SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape. bioRxiv. 2021 doi: 10.1101/2021.02.14.431043.
- White J.M., Delos S.E., Brecher M., Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 2008;43:189–219.
- Wibmer C.K., Ayres F., Hermanus T., Madzivhandila M., Kgagudi P., Oosthuysen B., Lambson B.E., de Oliveira T., Vermeulen M., van der Berg K., et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat. Med. 2021;27:622–625.
- Wood N., Bhattacharya T., Keele B.F., Giorgi E., Liu M., Gaschen B., Daniels M., Ferrari G., Haynes B.F., McMichael A., et al. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog. 2009;5:e1000414.
- Worobey M., Gemmel M., Teuwen D.E., Haselkorn T., Kunstman K., Bunce M., Muyembe J.J., Kabongo J.M.M., Kalengayi R.M., Van Marck E., et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature. 2008;455:661–664.
- Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260–1263.
- Wrobel A.G., Benton D.J., Xu P., Roustan C., Martin S.R., Rosenthal P.B., Skehel J.J., Gamblin S.J. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat. Struct. Mol. Biol. 2020;27:763–767.
- Wu N.C., Otwinowski J., Thompson A.J., Nycholat C.M., Nourmohammad A., Wilson I.A. Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape. Nat. Commun. 2020;11:1233.
- Zhang M., Foley B., Schultz A.-K., Macke J.P., Bulla I., Stanke M., Morgenstern B., Korber B., Leitner T. The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology. 2010;7:25.
- Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273.
- Zhu T., Korber B.T., Nahmias A.J., Hooper E., Sharp P.M., Ho D.D. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature. 1998;391:594–597.
Source: PubMed